about
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playRevolutionizing Alzheimer's disease and clinical trials through biomarkersWhat can imaging tell us about cognitive impairment and dementia?Insight into the Molecular Imaging of Alzheimer's DiseaseAmyloid positron emission tomography and cognitive reservePET Imaging of Epigenetic Influences on Alzheimer's DiseaseNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseClinical molecular imaging with radiotracers: current statusAcute and chronic traumatic encephalopathies: pathogenesis and biomarkers.Brain imaging in Alzheimer diseaseBiomarkers in dementia: clinical utility and new directionsClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersHarmonized diagnostic criteria for Alzheimer's disease: recommendationsAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseBrain PET in the diagnosis of Alzheimer's diseaseUshering in the study and treatment of preclinical Alzheimer diseaseThe use of (18)F-2-fluorodeoxyglucose (FDG) to label antibody fragments for immuno-PET of pancreatic cancer.Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationEvaluating and treating neurobehavioral symptoms in professional American football players: Lessons from a case series.18F-florbetaben Aβ imaging in mild cognitive impairmentMolecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain TissueNeuroimaging biomarkers of neurodegenerative diseases and dementiaThe diagnosis and management of mild cognitive impairment: a clinical review.Spreading of pathology in neurodegenerative diseases: a focus on human studiesAlzheimer's disease: Unique markers for diagnosis & new treatment modalitiesFlorbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainThe neuropathology of traumatic brain injury.APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.PET amyloid-beta imaging in preclinical Alzheimer's diseaseCerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults.Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyCortical β-amyloid levels and neurocognitive performance after cardiac surgery.Primary progressive aphasia and Alzheimer's disease: brief history, recent evidence.Neuronuclear imaging in the evaluation of dementia and mild decline in cognition.Neuroimaging of dementia in 2013: what radiologists need to know.A data-driven model of biomarker changes in sporadic Alzheimer's disease.Imaging frontotemporal lobar degeneration.Current status and future role of brain PET/MRI in clinical and research settings.
P2860
Q24594531-4E891748-C00B-490C-A9E8-D48F31F0D9C9Q26744882-25F3B7CE-C480-4F18-894B-9F9BAC17F310Q26749292-4DFECC40-053A-43D8-BD93-FA72BAFE5025Q26765945-328BBECB-6989-480D-A80C-F57F84CF2E5AQ26769755-7DDB9524-CD60-4D6C-A37C-4721747590AAQ26776178-E9A93363-226D-4304-8394-E85BD3B31388Q26783306-7D7D9FA3-9540-4494-8F1E-5ABE5B98CDE3Q26994741-46E5746A-DF70-46DC-82D3-DC9DADCAD5F0Q26995259-59035F22-8F25-4575-A94D-E8FDD266699BQ26996299-C17494FA-A1CC-4D93-A944-791B806650BFQ27007086-63F9203E-1C5B-4697-9BCD-9C80DD6B80E4Q27008249-1B719F76-02F1-42E7-B104-062AAFB1AB18Q27009157-5E31CBE0-859F-484D-8C45-44AD1DAD5232Q27009411-EAE631F2-FEA1-4A9D-9955-6D362755F4F4Q27011549-CC0BF282-363A-42C9-A9C1-C5F3FBDA96BCQ27014791-DDDB26A0-3A65-4BD6-85E0-A524640877AFQ27300759-336F1ECC-DE9F-40DB-B55C-C249A355E500Q27303745-59857C41-0EA5-48CC-B2A5-71C37518C96AQ27312607-03E1AAF8-2825-4D0D-9401-D52FF829026EQ27499311-05D4BF10-67EC-4FBE-947E-580AA9594B7DQ27679935-46D94274-8199-4FDC-AA78-494212EC8FE8Q27691820-72FA0495-DA47-4F39-915A-50DD39F40A4BQ27693353-9C404E8D-3AA3-4B07-95F4-A0B38698E529Q28082279-0E1121A3-F023-4891-9AF5-76A956DA3385Q28085139-FAB06ACA-BDAD-48D9-A063-B693CBD3D031Q28085541-5A1A5370-7F50-48AB-AB1D-613946162EFBQ28397809-483B472E-2C52-4167-8A3E-4C51BA1DDDCDQ29416986-37B9152F-02FD-463D-9864-D6AF7BF1688FQ30040695-950340B0-5A28-4490-9F98-7421D5C09813Q30275833-622E70D5-E57A-433F-869A-986D9CF422B9Q30403393-DF69EE0F-D34F-442E-939E-2FCE1B6A77A5Q30506492-2176A6EF-1F27-41C3-B41E-770B27CEBEE2Q30529034-9CC14C28-3EC4-4223-9093-D62DC4EEF789Q30546198-12FC5793-8421-4545-8767-4CD7964AB805Q30559809-4C7BF561-16EE-440F-914E-31BA23A7D7BEQ30571571-9CCD5E42-A48D-443B-ACEB-807C56BE19B1Q30654332-4BAE769F-8CAC-4815-9354-0AF38F105CB9Q30835966-13472C71-63CC-4C5F-A84C-5A18DEF17E32Q30846573-83C0DCA1-9355-48A5-9ECB-BC885B6928FAQ30883711-B349F673-1FC1-47CE-912B-7580E565C835
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@ast
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en-gb
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@nl
type
label
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@ast
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en-gb
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@nl
altLabel
Use of florbetapir-PET for imaging beta-amyloid pathology
@en
prefLabel
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@ast
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en-gb
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@nl
P3181
P356
P1476
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
@en
P2093
Christopher M. Clark
P3181
P356
10.1001/JAMA.2010.2008
P407
P577
2011-01-19T00:00:00Z